Literature DB >> 27285520

Beyond the Black Box Approach to Ethics! Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".

Lars Sandman1,2, Erik Gustavsson3.   

Abstract

In the editorial published in this journal, Daniels and colleagues argue that his and Sabin's accountability for reasonableness (A4R) framework should be used to handle ethical issues in the health technology assessment (HTA)-process, especially concerning fairness. In contrast to this suggestion, it is argued that such an approach risks suffering from the irrrelevance or insufficiency they warn against. This is for a number of reasons: lack of comprehensiveness, lack of guidance for how to assess ethical issues within the "black box" of A4R as to issues covered, competence and legitimate arguments and finally seemingly accepting consensus as the final verdict on ethical issues. We argue that the HTA community is already in a position to move beyond this black box approach.
© 2016 by Kerman University of Medical Sciences.

Entities:  

Keywords:  Accountability for Reasonableness (A4R); Ethical Analysis; Ethical Competence; Ethics; Health Technology Assessment (HTA)

Mesh:

Year:  2016        PMID: 27285520      PMCID: PMC4885733          DOI: 10.15171/ijhpm.2016.43

Source DB:  PubMed          Journal:  Int J Health Policy Manag        ISSN: 2322-5939


  6 in total

1.  Different methods for ethical analysis in health technology assessment: an empirical study.

Authors:  Samuli I Saarni; Annette Braunack-Mayer; Bjørn Hofmann; Gert Jan van der Wilt
Journal:  Int J Technol Assess Health Care       Date:  2011-10       Impact factor: 2.188

2.  Expanded HTA: Enhancing Fairness and Legitimacy.

Authors:  Norman Daniels; Thalia Porteny; Julian Urritia
Journal:  Int J Health Policy Manag       Date:  2015-11-06

3.  Toward a procedure for integrating moral issues in health technology assessment.

Authors:  Bjørn Hofmann
Journal:  Int J Technol Assess Health Care       Date:  2005       Impact factor: 2.188

4.  Improving ethics analysis in health technology assessment.

Authors:  Katherine Duthie; Kenneth Bond
Journal:  Int J Technol Assess Health Care       Date:  2011-01-25       Impact factor: 2.188

Review 5.  Social value judgments in healthcare: a philosophical critique.

Authors:  Laura Biron; Benedict Rumbold; Ruth Faden
Journal:  J Health Organ Manag       Date:  2012

6.  Framework for systematic identification of ethical aspects of healthcare technologies: the SBU approach.

Authors:  Emelie Heintz; Laura Lintamo; Monica Hultcrantz; Stella Jacobson; Ragnar Levi; Christian Munthe; Sofia Tranæus; Pernilla Östlund; Lars Sandman
Journal:  Int J Technol Assess Health Care       Date:  2015-01       Impact factor: 2.188

  6 in total
  4 in total

1.  The Need for Global Application of the Accountability for Reasonableness Approach to Support Sustainable Outcomes Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".

Authors:  Jens Byskov; Stephen Oswald Maluka; Bruno Marchal; Elizabeth H Shayo; Salome Bukachi; Oseph M Zulu; Erik Blas; Charles Michelo; Benedict Ndawi; Anna-Karin Hurtig
Journal:  Int J Health Policy Manag       Date:  2017-02-01

2.  Ethics in HTA: Examining the "Need for Expansion".

Authors:  Payam Abrishami; Wija Oortwijn; Bjørn Hofmann
Journal:  Int J Health Policy Manag       Date:  2017-10-01

3.  Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study.

Authors:  Monika Wagner; Dima Samaha; Roman Casciano; Matthew Brougham; Payam Abrishami; Charles Petrie; Bernard Avouac; Lorenzo Mantovani; Antonio Sarría-Santamera; Paul Kind; Michael Schlander; Michele Tringali
Journal:  Int J Health Policy Manag       Date:  2019-07-01

4.  Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer.

Authors:  Beata Kiselova Bilekova; Beata Gavurova; Vladimír Rogalewicz
Journal:  Health Econ Rev       Date:  2018-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.